$ChemoCentryx(CCXI)$ 本文件报告了Churchill Capital Corp XI实益所有权的变更。Churchill Sponsor XI LLC、Michael Klein和M. Klein Associates, Inc.共同持有约25.67%的已发行普通股,共计14,300,000股。这些股份的总购买价格为5,025,000美元,由保荐人的营运资金提供。文件详细说明了创始人股...
Churchill Capital XI(CCXI)
2025-12-17 10:45
$ChemoCentryx(CCXI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-25-122487 Size: 2 KB 网页链接
Churchill Capital XI(CCXI)
2025-12-17 10:45
$ChemoCentryx(CCXI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-25-122489 Size: 9 KB 网页链接
Churchill Capital XI(CCXI)
02-06 05:35
$ChemoCentryx(CCXI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-26-012794 Act: 34 Size: 274 KB 网页链接
Churchill Capital XI(CCXI)
昨天21:35
$Churchill Capital XI(CCXI)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-26-015889 Act: 34 Size: 27 KB 网页链接
$Churchill Capital XI(CCXI)$ Adage Capital Management, L.P. (ACM) 连同 Robert Atchinson 和 Phillip Gross 已提交了13G表格,报告持有Churchill Capital Corp XI的2,700,000股A类普通股的受益所有权。截至2025年12月31日,这代表了公司已发行股份的6.44%。这些股份是在正常业务过程中获得的,...
Churchill Capital XI(CCXI)
2025-12-11 19:05
$ChemoCentryx(CCXI)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-25-120290 Act: 33 Size: 5 MB 网页链接